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Cytidine-5′-diphosphate-1,2,-diacyl-sn-
glycerol synthetaseCardiolipin (CL) is a major phospholipid involved in energy metabolism mammalian mitochondria and
fatty acid transport protein-1 (FATP-1) is a fatty acid transport protein that may regulate the intracellular
level of fatty acyl-Coenzyme A's. Since fatty acids are required for oxidative phosphorylation via
mitochondrial oxidation, we examined the effect of altering FATP-1 levels on CL biosynthesis. HEK-293
mock- and FATP-1 siRNA transfected cells or mock and FATP-1 expressing cells were incubated for 24 h
with 0.1 mM oleic acid bound to albumin (1:1 molar ratio) then incubated for 24 h with 0.1 mM [1,3-3H]
glycerol and radioactivity incorporated into CL determined. FATP-1 siRNA transfected cells exhibited
reduced FATP-1 mRNA and increased incorporation of [1,3-3H]glycerol into CL (2-fold, pb0.05) compared
to controls indicating elevation in de novo CL biosynthesis. The reason for this was an increase in [1,3-3H]
glycerol uptake and increase in activity and mRNA expression of the CL biosynthetic enzymes. In contrast,
expression of FATP-1 resulted a reduction in incorporation of [1,3-3H]glycerol into CL (65%, pb0.05)
indicating reduced CL synthesis. [1,3-3H]Glycerol uptake was unaltered whereas activity of cytidine-5′-
diphosphate-1,2-diacyl-sn-glycerol synthetase (CDS) and CDS-2 mRNA expression were reduced in FATP-1
expressing cells compared to control. In addition, in vitro CDS activity was reduced by exogenous addition
of oleoyl-Coenzyme A. The data indicate that CL de novo biosynthesis may be regulated by FATP-1 through
CDS-2 expression in HEK 293 cells.© 2009 Elsevier B.V. All rights reserved.1. IntroductionCardiolipin (CL) is a polyglycerolphospholipid found in and
synthesized exclusively in the mitochondria of mammalian tissues
[reviewed in 1–4]. CL is localized to both the inner and outer
mitochondrial membranes and within intermembrane contact sites.
CL plays an important role in many mitochondria mediated functions.
CL is required for the activation of a number of key mitochondrial
enzymes, such as cytochrome c oxidase and other proteins involved in
the electron transport chain, “gluing” the respiratory chain together
[1–4,5]. Loss of CL leads to a reduction inmitochondrial respiration [6].
In addition, studies have implicated CL loss in the regulation of
mitochondrial-mediated apoptosis and Barth syndrome [reviewed in
7–12]. Thus, the appropriate content of CL is an important require-rol; CDP-DG, cytidine-5′-dipho-
S, cytidine-5′-diphosphate-1,2,-
osphate synthase; CLS, cardioli-
y and Therapeutics, University
Avenue, Winnipeg, Manitoba,
9 3932.
atch).
ll rights reserved.ment for activation of enzymes involved in mitochondrial respiration
and in the control of programmed cell death.
In mammalian tissues CL is synthesized de novo by the cytidine-5′-
diphosphate-1,2-diacyl-sn-glycerol (CDP-DG) pathway [13]. The ﬁrst
step is catalyzed by cytidine-5′-diphosphate-1,2-diacyl-sn-glycerol
synthetase (CDS) [14]. CDS catalyzes the conversion of phosphatidic
acid (PA) to CDP-DG. In the heart and various mammalian cell lines
CDS was shown to be a rate-limiting step of CL biosynthesis [reviewed
in 1]. Two CDS enzymes, CDS-1 and CDS-2, have been cloned and
characterized in human,mouse, rat and pig [15–21]. In the second step
of the CDP-DG pathway CDP-DG is condensed with sn-glycerol-3-
phosphate to form phosphatidylglycerol (PG) catalyzed by PG
phosphate synthase (PGPS) and this is followed by rapid depho-
sphorylation to PG [14]. In the ﬁnal step, PG condenses with another
CDP-DG molecule to form CL and this is catalyzed by cardiolipin
synthase (CLS) [22]. The gene encoding human CLS (hCLS-1) was
recently identiﬁed and characterized [23–25].
Fatty acids are major components of glycerophospholipids and are
required for energy production via beta-oxidation [reviewed in 26].
Fatty acids are taken up into cells either by diffusion due to their
solubility in the membrane or by proteins which facilitate their
transport [reviewed in 26–29]. Currently three protein families have
been implicated in fatty transport, fatty acid translocase/CD 36,
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protein (FATP). Five members of the FATP family have been described
in murine cells and a sixth identiﬁed from analysis of the human
genome [30]. FATP-1 plays a key role in regulating fatty acid transport
in mammalian cells. FATP-1 is a bifunctional protein with both
transport and long-chain acyl-Coenzyme A synthetase activities [31].
Since fatty acid import into cells plays a key role in fatty acid oxidation
and CL is required for oxidative phosphorylation, we examined
whether altering the level of fatty acid transport protein in HEK 293
cells could regulate CL biosynthesis. We show that knock down of
FATP-1 stimulates and expression of FATP-1 inhibits de novo CL
synthesis.
2. Materials and methods
2.1. Materials
[14C]Glycerol-3-phosphate, [5-3H]cytidine-5′-triphophate, and
[1,3-3H]glycerol and were obtained from either Dupont, Mississauga,
Ontario, or Amersham, Oakville, Ontario, Canada. Phosphatidyl[14C]
glycerol was synthesized from [14C]glycerol-3-phosphate as described
previously [32]. Human Embryonic Kidney (HEK) 293 cells were
obtained from the American Type Culture Collection. Dulbecco's
modiﬁed Eagle's medium (DMEM), fetal bovine serum (FBS) and
Trizol reagent were obtained from Canadian Life Technologies
(GIBCO), Burlington, Ontario, Canada. C8 HEK 293 cells expressing
FATP-1 were a generous gift from Dr. David A. Bernlohr, University of
Minnesota. Lipid standards were obtained from the Serdary Research
Laboratories, Englewood Cliffs, New Jersey, USA. Thin layer chromato-
graphic plates (silica gel G, 0.25 mm thickness) were obtained from
Fisher Scientiﬁc, Winnipeg, Canada. Ecolite scintillant was obtained
from ICN Biochemicals, Montreal, Quebec, Canada. Primers were
designed and synthesized from Invitrogen, Burlington, Ontario,
Canada. Flexitube siRNA was obtained from Qiagen, Cambridge,
Massachusetts, USA. All other biochemicals were certiﬁed ACS grade
and obtained from either Fisher Scientiﬁc, Winnipeg, Manitoba,
Canada or Sigma Chemical Company, St. Louis, MO. USA.
2.2. Culturing, radiolabeling and harvesting of cells
HEK 293 cells were transfected with FATP-1 subcloned into
pcDNA3.0 (C8) or transformed with plasmid control vector (mock)
as previously described [33]. Cell lines were maintained on DMEM
with 10% FBS and incubated at 37 °C in 5.0% CO2. Cells expressing
FATP-1 were selected with the addition of 400 µg/ml geneticin. In
radiolabeling experiments, mock and C8 cell lines were incubated
with 0.1 mM oleic acid bound to albumin (1:1 molar ratio) for 24 h
and then incubated with 0.1 mM [1,3-3H]glycerol (10 μCi/dish) for
24 h. Subsequent to incubation themediumwas removed and the cells
washed twice with 2 ml of ice-cold phosphate-buffered saline (PBS).
The PBS was removed and 2 ml of methanol:water (1:1 v/v) was
added. The cells were harvested using a rubber policeman into test
tubes. The mixture was vortexed, and a 50 μl aliquot was taken for
protein determination and a 10 μl or 25 μl aliquot taken for
determination of total radioactivity. 2 ml of chloroform was added
to the tubes followed by 0.5 ml 0.9% NaCl to initiate phase separation.
The tubes were vortexed and then centrifuged at 2000 rpm for 10 min
(bench top centrifuge), the aqueous phase was removed and 2 ml
theoretical upper phase (48 ml methanol, 47 ml 0.9% NaCl, 3 ml
chloroform) was added to wash the organic phase. The tubes were
vortexed and centrifuged as described above and the aqueous phase
removed. The organic phase was dried under a stream of N2 gas and
resuspended in 50 μl of chloroform:methanol (2:1 v/v). A 40 μl aliquot
of organic phase was placed onto a thin-layer plate along with
phospholipid standards and phospholipids were separated by two-
dimensional thin-layer chromatography and radioactivity incorpo-rated into phospholipids determined as described [32]. For determi-
nation of phospholipid pool sizes, in some experiments, a 40 μl aliquot
of organic phase was placed onto a thin-layer plate in the absence of
phospholipid standards and phospholipids were separated by two-
dimensional thin-layer chromatography as pool size determined as
described [34].
2.3. siRNA transient transfection
Transient transfection of HEK 293 cells followed the Fast-Forward
Transfection of Adherent cells with siRNA in 100 mm dishes protocol
provided in the HiPerFect Reagent handbook (Qiagen). Cells were
seeded onto 100 mm dishes (3.0×106 cells/cm2) in 10 ml of fresh
media. Cells were seeded 2 h prior to the addition of siRNA complexes.
The FATP-1 siRNA target sequence was 5′-CCC TCT GAA GCT GTT CCT
CTA. Complexes of 5 nM FATP-1 siRNA were formed by mixing siRNA
with HiPerFect Reagent (Qiagen, Massachusetts, USA) and incubating
for 10 min at room temperature. Cells were incubated with these
complexes at 37 °C, 5.0% CO2 for 48 h. Mock treated cells underwent
the same transfection process but were incubated with only the
HiPerFect reagent. mRNA was isolated with Trizol reagent (GIBCO) to
monitor FATP-1 gene silencing and measure the effectiveness of
transfection. Mock and siRNA transfected cells were incubated with
0.1 mM oleic acid bound to albumin (1:1 molar ratio) for 24 h.
2.4. Real-time RT-PCR analysis
RNA from oleate-treated mock, FATP-1 knockdown and expressing
cells was isolated using Trizol reagent (GIBCO) according to the
manufacturer's instructions. Measurement of gene expression by
quantitative analysis was carried out using a Mastercycler ep realplex
system (Eppendorf). Primers and hybridization probes were synthe-
sized by Invitrogen (Ontario, Canada) and Qiagen (Massachusetts,
USA). Quantitative real-time RT-PCR analysis of human cytidine-5′-
diphosphate-1,2-diacyl-sn-glycerol synthetase-2 (CDS-2), PGPS, CLS,
FATP-1 and β-actin gene expressionwas carried out using a Quantitect
Probe RT-PCR SYBRGreen kit (Qiagen). The sequences of the screening
primers were; CDS-2, forward 5′-GTC AGC ATC CCT TTG TCG AT,
reverse 5′-CCA AGC AAA CTG ATT CAG CA; PGPS, forward 5′-TCG GCC
TCC AGC ACA TTA AG, reverse 5′-AGT CAC TCA GGT TTG CAC CG; CLS,
forward 5′-CGA GAG ATG TAA TGT TGA TTG CTG, reverse 5′-CGA ACC
GTG GTG TTG GAA GAG TT[FAM]G; FATP-1, forward 5′-CCA CTT GGA
TGT CAC CAC TG, reverse 5′-GTG GGA CCC TCC AGT AGA CA; β-actin,
forward 5′-AGA AAA TCT GGC ACC ACA AC, reverse 5′-GGG GTG TTG
AAG GTC TCA AA. PCR ampliﬁcation of the housekeeping gene β-actin
was carried out for each sample as a control for sample loading and to
allow normalization among samples. The PCR condition for the each
sample was 40 cycles of heating to 95 °C for 15 s, cooling to 60 °C for
30 s and 72 °C for 30 s. A melting curve was taken of each product to
determine purity levels. To determine the relative gene expression
between mock and FATP-1 expressing cells or mock and FATP-1
knockdown cells ΔΔCt values were calculated. ΔΔCt values were
calculated by subtracting theΔCt (sample) from theΔCt (control). The
β actin control was normalized to 1.0 and each target gene was then
normalized following this equation. Results were represented as the
mean of three RNA samples from each group.
2.5. Preparation of mitochondrial fractions and enzyme assays
All isolation procedures were preformed at 4 °C. Cells were
incubated with 0.1 mM oleic acid bound to albumin (1:1 molar ratio)
for 24 h. Cells were harvested using PBS and pipetted into test tubes.
The tubes were centrifuged at 500 ×g for 10min and the PBS removed.
Addition of 1 ml homogenizing buffer (0.25 M sucrose, 10 mM Tris–
HCL, 0.145 M NaCl, pH 7.4) was followed by homogenization by 50
strokes of a tight ﬁtting Dounce A homogenizer. The homogenate was
Table 1
[1,3-3H]Glycerol incorporation into phospholipids in mock and FATP-1 siRNA
transfected cells.
Phospholipid Mock FATP-1
(dpm/mg protein×106) knockdown
Cardiolipin 1.7±0.4 3.3±0.6⁎
Phosphatidylglycerol 0.4±0.1 1.1±0.1⁎
Phosphatidylcholine 17.6±3.9 37.6±2.9⁎
Phosphatidylethanolamine 6.4±1.5 13.7±1.1⁎
Phosphatidylserine/inositol 1.1±0.3 2.0±0.1⁎
Phosphatidic acid 1.1±0.2 2.5±0.4⁎
Total radioactivity 30.6±0.7 62.1±0.5⁎
Mock and FATP-1 siRNA transfected cells were incubated with 0.1 mM oleate bound to
albumin (1:1 molar ratio) for 24 h and then incubated with 0.1 mM [1,3-3H]glycerol for
24 h and radioactivity incorporated into phospholipids determined as described in
Materials and methods. Data represents the mean±S.D. of three dishes.
⁎ pb0.05.
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centrifuged at 12,000 ×g for 15 min. The resulting pellet was
resuspended in 0.5 ml of homogenizing buffer by a tight ﬁtting
Dounce A homogenizer and used as the source of mitochondrial
fraction for assay of mitochondrial enzyme activities. CDS, PGPS and
CLS activities were determined as previously described [32].
2.6. Other determinations
Isolation and determination of long-chain acyl-CoA from mito-
chondrial fractions of HEK 293 mock and C8 cells expressing FATP-1
were previously described [35]. Acyl-CoA content in the samples was
determined using gas chromatography and data analyzed by a
Shimadzu Chromatopac CR501. Protein was measured by the method
of Lowry [36]. In some experiments, equivalent protein amounts of
mock and FATP-1 expressing cells were separated by two-dimensional
isoelectric focusing/sodium dodecyl sulphate polyacrylamide gel
electrophoresis and stained as described [37].
3. Results
Since fatty acid import into cells plays a key role in fatty acid
oxidation and CL is required for oxidative phosphorylation, we
examined whether altering the level of FATP-1 regulated de novo CL
biosynthesis. HEK 293 cells were transfected with FATP-1 siRNA for
48 h and FATP-1 mRNA expression was determined by real time-PCR.
FATP-1 mRNA expression was signiﬁcantly knocked down (Fig. 1).
Mock and FATP-1 siRNA transfected cells were then incubated with
0.1 mM oleate (bound to albumin 1:1) for 24 h and then with 0.1 mM
[1,3-3H]glycerol for 24 h and the radioactivity incorporated into
phospholipids determined. Incorporation of [1,3-3H]glycerol into CL
was increased 2-fold (pb0.05) in FATP-1 siRNA transfected cells
compared to mock transfected controls (Table 1). In addition, [1,3-3H]
glycerol incorporated into other glycerophospholipids was also
increased approximately 2-fold (pb0.05). Total uptake of [1,3-3H]
glycerol was increased 2-fold (pb0.05) in FATP-1 siRNA transfected
cells compared tomock transfected controls. These data indicated that
knock downof FATP-1 inHEK293 cells stimulated CL andphospholipid
de novo synthesis from glycerol at the level of glycerol uptake.
The pool size of CL and the major phospholipids, phosphatidy-
lethanolamine (PE) and phosphatidylcholine (PC)were determined in
mock and FATP-1 siRNA transfected cells. The pool size of CL was
increased 2.3-fold (pb0.05) in FATP-1 siRNA transfected cells
compared to controls (Fig. 2A). However, the overall phospholipid
content in the cells did not change as no alterations in the pool size of
the major phospholipids PE and PC were observed. Thus, de novo CL
synthesis was increased in FATP-1 siRNA transfected HEK 293 cells
incubated with oleate.
The reason for the increase in CL was examined. The mitochondrial
fractions were prepared frommock and FATP-1 siRNA transfected cellsFig. 1. FATP-1 mRNA expression in mock transfected HEK 293 cells and FATP-1 siRNA
transfected cells. Mock and FATP-1 siRNA transfected cells were incubated with 0.1 mM
oleate bound to albumin (1:1 molar ratio) for 24 h and total RNA isolated and
expression of FATP-1 and β-actin mRNA determined as described in Materials and
methods. Data represents the mean of three dishes.and the activities of the enzymes of the CDP-DG pathway determined.
CDS, PGPS and CLS activities were increased 23% (pb0.05), 21%
pb0.05) and 71% (pb0.05), respectively, in FATP-1 siRNA transfected
cells compared to controls (Table 2A). Thus, the increase in CL content
in FATP-1 siRNA transfected cells was due to an increase in the
activities of the enzymes of the CDP-DG pathway of CL synthesis.
The reason for the increase in enzyme activities of CDS, PGPS and
CLS in oleate-treated FATP-1 siRNA transfected cells was examined.
Total mRNA was prepared from mock and FATP-1 siRNA transfected
cells and expression of CDS-2, PGPS and CLS mRNA were examined.
CDS-2, PGPS and CLS mRNA expressions were all elevated in the FATP-
1 siRNA transfected cells to the mock transfected cells (Fig. 3A–C).
Thus, the content of CL and increased [1,3-3H]glycerol incorporation
into CL in oleate-treated FATP-1 siRNA transfected cells was due to an
increase in activity and mRNA expression of enzymes of the CDP-DG
pathway of CL synthesis.Fig. 2. Pool size of major glycerophospholipids in FATP-1 siRNA transfected cells or
FATP-1 expressing C8 cells incubated with oleate. Mock and FATP-1 siRNA transfected
cells (A) or mock and FATP-1 expressing C8 cells (B) were incubated with 0.1 mM oleate
bound to albumin (1:1 molar ratio) for 24 h and the pool size of the major
glycerophospholipids were determined as described in Materials and methods. Data
represents the mean±S.D. of three dishes and is expressed as a percent of total
phospholipid. ⁎pb0.05.
Table 3
[1,3-3H]Glycerol incorporation into phosholipids in C8 cells expressing FATP-1.
Phospholipid Mock C8
(dpm/mg protein×105)
Cardiolipin 3.5±1.4 1.2±0.4⁎
Phosphatidylglycerol 2.4±0.2 1.7±0.4⁎
Phosphatidylcholine 30.7±8.4 12.4±4.4⁎
Phosphatidylethanolamine 8.8±1.9 5.1±0.9
Phosphatidyserine 0.9±0.2 0.6±0.2
Phosphatidic acid 0.6±0.1 0.4±0.3
Total radioactivity 12.4±0.1 11.1±0.3
HEK 293 mock and C8 cells expressing FATP-1 were incubated with 0.1 mM oleate
bound to albumin (1:1 molar ratio) for 24 h and then incubated with 0.1 mM [1,3-3H]
glycerol for 24 h and radioactivity incorporated into phospholipids determined as
described in Materials and methods. Data represents the mean±S.D. of three dishes.
⁎ pb0.05.
Table 2
Enzyme activities in FATP-1 siRNA transfected cells or FATP-1 expressing cells incubated
with oleate.
A.
Enzyme Mock
(pmol/min/mg protein)
FATP-1
knockdown
CDS 23.9±0.1 31.0±0.6⁎
PGPS 57.1±5.8 198.8±3.7⁎
CLS 0.7±0.3 2.4±0.6⁎
B.
Enzyme Mock
(pmol/min/mg protein)
C8
CDS 41.2±6.1 25.5±2.4⁎
PGP 162.8±31.5 163.1±6.9
CLS 1.0±0.2 0.9±0.2
Mock and FATP-1 siRNA transfected cells (A) or mock and FATP-1 expressing C8 cells (B)
were incubated with 0.1 mM oleate bound to albumin (1:1 molar ratio) for 24 h and the
enzyme activities of the CDP-DG pathway determined as described in Materials and
methods. Data represents the mean±S.D. of three dishes.
⁎ pb0.05.
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CL synthesis we examined if expression of FATP-1 in HEK 293 cells had
the corollary effect on CL synthesis. Mock or C8 cells expressing FATP-Fig. 3. CDS-2, PGPS and CLS mRNA expression in mock and FATP-1 siRNA transfected
cells. Mock and FATP-1 siRNA transfected cells were incubated with 0.1 mM oleate
bound to albumin (1:1 molar ratio) for 24 h and total RNA was isolated and expression
of CDS-2 (A), PGPS (B) and CLS (C) mRNA determined as described in Materials and
methods. Data represents the mean of three dishes.1 were incubated with 0.1 mM oleate (bound to albumin 1:1) for 24 h
and then with 0.1 mM 1,3-3H]glycerol for 24 h and radioactivity
incorporation into CL determined. Incorporation of [1,3-3H]glycerol
into CL was reduced 65% (pb0.05) in C8 cells compared to control
(Table 3). In addition, [1,3-3H]glycerol incorporated into PG and PC
was decreased. In contrast, total uptake of [1,3-3H]glycerol was
unaltered between C8 cells and controls. These data indicated that
expression of FATP-1 in HEK 293 cells inhibited CL synthesis from
glycerol.
The pool size of CL and the major phospholipids in FATP-1
expressing cells were examined. The pool size of CL and the other
major phospholipids (PE and PC) were unaltered between vector and
C8 cells treated with oleate (Fig. 2B). Thus, de novo CL biosynthesis
from [1,3-3H]glycerol was decreased in C8 cells expressing FATP-1
incubated with oleate but this did not affect the CL pool size. Since the
pool size of phospholipids was unaltered we examined if FATP-1
expression altered protein expression in these cells. Equivalent
protein amounts from mock and C8 cells were separated by two-
dimensional isoelectric focusing/sodium dodecyl sulphate polyacry-
lamide gel electrophoresis and stained as described in Materials and
methods. As seen in Fig. 4, expression of FATP-1 cells altered the
protein expression proﬁle compared to control. As expected the level
of FATP-1 protein was elevated (closed arrow B). In contrast, the level
of other several proteins (open arrows in B)was reduced. Thus, FATP-1
expression reduced the expression of several proteins in HEK 293 cells
and this may, in part, have accounted for the lowered [1,3-3H]glycerol
incorporation into CL.
The reason for the decrease in [1,3-3H]glycerol incorporation into
CL in C8 cells was then examined. Mitochondrial fractions were
isolated frommock and C8 cells and CL biosynthetic enzyme activities
determined. CDS activity was reduced 38% (pb0.05) in C8 cells
compared to controls (Table 2B). PGPS and CLS activities were
unaltered between control and C8 cells. The reason for the decrease in
CDS activity in C8 cells was examined. Mock and C8 cells were
incubated with 0.1 mMoleate for 24 h and total RNA isolated and CDS-
2 mRNA expression determined. CDS-2 mRNA expression was
decreased in C8 cells compared to controls (Fig. 5). FATP-1 exhibits
acyl-Coenzyme A synthetase activity [31] and expression of FATP-1 in
C8 cells was shown to elevate intracellular fatty acid levels [33]. A
previous study had indicated that CDS enzyme activity was inhibited
by oleic acid in isolated lymph node lymphocytes [39]. Mitochondrial
fractions from HEK 293 cells were prepared and CDS enzyme activity
determined in the absence or presence of various concentrations of
oleoyl-Coenzyme A. CDS in vitro activity was reduced in the presence
of 1 μM or greater concentrations of oleoyl-Coenzyme A (Fig. 6A). This
data indicated that the reduction in the CDS enzyme activity seen in
C8 cells expressing FATP-1 might also be in part due to increases in
fatty acyl-Coenzyme A in these cells. Next, long-chain acyl-Coenzyme
A levels were determined in control and C8 cells. Long-chain acyl-
Coenzyme As were signiﬁcantly increased 44% (pb0.05) in C8 cells
Fig. 4. Protein expression proﬁle in FATP-1 expressing cells. Equivalent amounts of protein lysates from mock (A) and C8 (B) cells were separated by two-dimensional isoelectric
focusing/sodium dodecyl sulphate polyacrylamide gel electrophoresis and stained as described in Materials and methods. Closed arrows in B indicate a protein whose level was
elevated; open arrows in B indicate proteins in which the level was reduced. A representative gel is depicted.
2019R.W. Mitchell, G.M. Hatch / Biochimica et Biophysica Acta 1788 (2009) 2015–2021compared to control (Fig. 6B). The elevated long-chain acyl-Coenzyme
A levels observed in C8 cells were consistent with a previous study in
rats in which supplementation with a Tallow diet resulted in elevated
liver acyl-Coenzyme A levels [38]. Thus, the decreased CL synthesis in
oleate-treated C8 cells could be due to reduction in CDS enzyme
activity, CDS-2 mRNA expression as well as elevation in intracellular
acyl-Coenzyme A.
4. Discussion
The objective of this study was to examine if altering the level of
FATP-1 in HEK 293 cells could regulate CL biosynthesis. Incorporation
of [1,3-3H]glycerol into CL was increased when FATP-1 was knocked
down in HEK 293 cells compared to control. In addition, CL mass was
elevated 2-fold when FATP-1 was knocked down in these cells. The
reason for the increased CL content was likely an increase in [1,3-3H]
glycerol uptake and utilization for CL synthesis and an increase in
activity and expression of the CL biosynthetic enzymes. The alteration
in CL synthesis was reversed in FATP-1 expressing cells. In this case,
[1,3-3H]glycerol incorporation into CL was reduced in cells expressing
FATP-1 compared to control even though [1,3-3H]glycerol uptake was
unaltered. The reason for the decrease in [1,3-3H]glycerol incorpora-
tion into CL was a reduction in CDS enzyme activity and CDS-2 mRNA
expression. Interestingly, the content of CL was unaltered in FATP-1
expressing cells compared to controls. Although de novo CL synthesis
from [1,3-3H]glycerol was lower in these cells expressing FATP-1, it
was not surprising that there was no alteration in CL mass since
normal turnover of CL is slow, in a matter of days, in mammalian cellsFig. 5. CDS-2 mRNA expression in mock and C8 cells expressing FATP-1. Mock and C8
cells were incubated with 0.1 mM oleate bound to albumin (1:1 molar ratio) for 24 h
and total RNA isolated and expression of CDS-2 mRNA determined as described in
Materials and methods. Data represents the mean of three dishes.[reviewed in 2]. The above observations indicate that CL synthesis is
speciﬁcally modulated by FATP-1 knock down or expression.
Knock down of FATP-1 increased whereas FATP-1 expression did
not affect PGPS and CLS activities. CDS is a rate-limiting step of CL
biosynthesis in the CDP-DG pathway of mammalian cells [32]. CDS
activity was increased by FATP-1 knockdown and decreased by
FATP-1 expression in HEK 293 cells. These alterations in CDS
enzyme activity by alteration in FATP-1 expression suggest that the
modulation of CL biosynthesis by FATP-1 expression is likely
mediated through CDS. The reason for the increased CDS activity
in FATP-1 siRNA transfected cells was an increase in CDS-2 mRNAFig. 6. CDS activity in 293 cells in the presence of various concentrations of oleoyl-
Coenzyme A. (A) Mitochondrial fractions were prepared from HEK 293 cells and then
incubated with 0 μM or 0.01 μM or 0.1 μM or 1 μM or 5 μM oleoyl-Coenzyme A and CDS
activity determined as described in Materials and methods. (B) Long-chain acyl-
Coenzyme A were determined in mock and C8 incubated with 0.1 mM oleate bound to
albumin (1:1 molar ratio) for 24 h as described in Materials and methods. Data
represents the mean±S.D. of three dishes. ⁎pb0.05, ⁎⁎ pb0.01.
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FATP-1 expressing cells that exhibited a reduction in CDS activity.
CDS-2 mRNA expression is widespread throughout the body with
highest expression in the heart, brain and kidney [16–20]. In
contrast, CDS-1 mRNA expression is low in most tissues throughout
the body outside of the retina [16–20]. The above data suggest that
CL biosynthesis may be modulated by FATP-1 expression through
CDS activity and CDS-2 mRNA expression.
How does FATP-1 expression modulate CL biosynthesis through
CDS? Although we did not measure CDS-2 protein in these cells due to
a lack of an available antibody, the level of several proteins were
reduced in FATP-1 expressing cells. It is possible that CDS-2 may be
one of these proteins and lowered CDS-2 protein may have accounted
for the reduced CDS enzyme activity in FATP-1 expressing cells. In
addition to its fatty acid transport activity, FATP-1 is an acyl-Coenzyme
A synthetase that couples fatty acid synthesis to acyl-Coenzyme A
production [31]. CDS enzyme activity was shown to be inhibited by
oleic acid in isolated hog lymph node lymphocytes [39]. We observed
a reduction in CDS activity with addition of exogenous oleoyl-
Coenzyme A indicating that elevation in fatty acid, previously
observed in HEK 293 cells expressing FATP-1 [33], may inhibit CDS
enzyme activity in these cells. The free cytosolic concentration of acyl-
Coenzyme A esters is in the low nanomolar range, and unlikely
exceeds 0.2 μM under the most extreme conditions [40]. Thus, it is
likely that under normal physiological conditions CDS activitymay not
be regulated by cytosolic acyl-Coenzyme A levels. However, FATP-1
has been shown to collaborate and interact with carnitine palmitoyl-
transferase-1 (CPT1), which imports long-chain fatty acids into the
mitochondria [41]. This interaction would allow an increase in long-
chain acyl-Coenzyme A by FATP-1 acyl-Coenzyme A synthetase in the
cytosol to reﬂect an increase in acyl-Coenzyme A within the
mitochondria in C8 cells expressing FATP-1. Thus, the decrease in
CDS activity observed in FATP-1 expressing cells could be due in part
to an oleoyl-Coenzyme A accumulation within the mitochondria of
these cells. CDS activity was shown to be regulated by the composition
of PA [42]. For example, in rat brain membrane fractions a 20%
reduction in CDS activity was observed when 1-stearoyl-2-oleoyl-PA
was replaced with 1,2-dioleoyl-PA. Thus, increasing the oleate
concentration of the PA substrate may alter CDS activity through
substrate composition. We did not observe signiﬁcant changes in the
fatty acyl composition of PA in our experiments (data not shown).
Thus, regulation of CDS activity through PA also seems unlikely. It is
well documented that fatty acids have a signiﬁcant effect on RNA
abundance of genes encoding proteins involved in fatty acid
metabolism in mammals [43]. Fatty acids may increase the expression
of fatty acid transport proteins including carnitine palmitoyl transfer-
ase-1 and FATP [44]. Hepatocyte nuclear factor-4α (HNF-4α) is a
member of a transcription factor family involved in hepatocyte
differentiation and cellular metabolism [45,46]. HNF-4α is broadly
expressed with very high mRNA expression in the kidney [47].
Expression of HNF-4αmay be regulated by binding of long-chain acyl-
Coenzyme A's and coexpression of acyl-Coenzyme A synthetase
potentiated activation of HNF-4α [48]. Transcription factor binding
analysis of the CDS gene using PROMO predicts a potential HNF-4α
binding site. Since FATP-1 is an acyl-Coenzyme A synthetase [31 ]
alteration in expression of FATP-1 could potentially modulate HNF-4α
activation and hence CDS expression. This will form the basis for
future studies on the nature of regulation of CDS expression mediated
by FATP-1. In summary, altering FATP-1 levels in HEK 293 cells appears
to modulate CL synthesis via regulation through CDS activity and
expression.
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